In individuals with EGFRI-induced skin toxicities, the levels of various inflammatory cytokines are increased, including IL6, TNFα, and CCL2 (Lichtenberger et al., 2013; Mascia et al., 2013). The gene discussed is IL6; the disease is dermatological toxicity.